Table 2. Costs and health utilities.
a
In the U.S., the price of osimertinib, gefitinib, and erlotinib would be discounted at 17% to account for contract pricing [19]. In China, patients would receive donated osimertinib from the producer: the patient would pay for 4 months, followed by donations for 8 months in the first year, and then would pay for 3 months, followed by donations until disease progression or death.
Abbreviations: EGFR, epidermal growth factor receptor; PC, pemetrexed plus cisplatin; PFS, progression‐free survival; PS, progressed survival; SAE, serious adverse event (grade >3).